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Deletion of α-neurexin II results in autism-related behaviors
in mice
J Dachtler1, J Glasper2, RN Cohen1, JL Ivorra1, DJ Swiffen1, AJ Jackson1, MK Harte2, RJ Rodgers3 and SJ Clapcote1
Autism is a common and frequently disabling neurodevelopmental disorder with a strong genetic basis. Human genetic studies
have discovered mutations disrupting exons of the NRXN2 gene, which encodes the synaptic adhesion protein α-neurexin II
(Nrxn2α), in two unrelated individuals with autism, but a causal link between NRXN2 and the disorder remains unclear. To begin to
test the hypothesis that Nrxn2α deﬁciency contributes to the symptoms of autism, we employed Nrxn2α knockout (KO) mice that
genetically model Nrxn2α deﬁciency in vivo. We report that Nrxn2α KO mice displayed deﬁcits in sociability and social memory
when exposed to novel conspeciﬁcs. In tests of exploratory activity, Nrxn2α KO mice displayed an anxiety-like phenotype in
comparison with wild-type littermates, with thigmotaxis in an open ﬁeld, less time spent in the open arms of an elevated plus maze,
more time spent in the enclosure of an emergence test and less time spent exploring novel objects. However, Nrxn2α KO mice did
not exhibit any obvious changes in prepulse inhibition or in passive avoidance learning. Real-time PCR analysis of the frontal cortex
and hippocampus revealed signiﬁcant decreases in the mRNA levels of genes encoding proteins involved in both excitatory and
inhibitory transmission. Quantiﬁcation of protein expression revealed that Munc18-1, encoded by Stxbp1, was signiﬁcantly
decreased in the hippocampus of Nrxn2α KO mice, which is suggestive of deﬁciencies in presynaptic vesicular release. Our ﬁndings
demonstrate a causal role for the loss of Nrxn2α in the genesis of autism-related behaviors in mice.
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INTRODUCTION
Autism is a widespread cognitive disorder characterized by
impairments in social interactions, communication and language
development, that can be accompanied by stereotyped patterns
of behavior. Autism is a highly heritable disorder with con-
cordance rates as high as 90% for monozygotic twins,1 but the
underlying molecular and neuropathophysiological basis is
unknown in most cases. However, recent genetic and genomic
studies have implicated a large number of genes in autism,2 many
of which encode synaptic proteins,3 indicating that synaptic
dysfunction may have a critical role in autism.
The neurexins are a family of synaptic adhesion proteins
encoded by paralogous genes (NRXN1-3) that have a key role in
synaptic function. Each gene is transcribed in neurons from two
independent promoters to yield longer (α) proteins with six
laminin/neurexin/sex hormone (LNS) binding domains, and
shorter (β) proteins with one LNS binding domain. Intracellularly,
α-neurexin binds to CASK, Mint, Munc18, syntenin and synapto-
tagmin, suggesting a role in vesicular release.4–6 Postsynaptic
binding with PSD-95 or gephyrin via neuroligins (also associated
with autism7), leucine-rich repeat transmembrane proteins
(LRRTMs) or dystroglycan can directly inﬂuence NMDA, AMPA or
GABAergic receptors at the synapse, thereby altering a cell’s
excitatory or inhibitory tone.8–10 The promoter for α-neurexin II
(Nrxn2α) transcripts lies upstream of NRXN2 exon 1, whereas the
promoter for β-neurexin II is located in the intron downstream of
exon 17.11 The ﬁrst evidence for a potential role of NRXN2 in
autism was provided by a report of a frameshift mutation within
NRXN2 exon 12 in a boy with autism and his father with severe
language delay.12 This mutation results in a truncated Nrxn2α
protein that lacks the binding sites for the established post-
synaptic binding partners LRRTM2 and neuroligin-2, but does not
affect β-neurexin II.12 Subsequently, a 21-year-old man with a
clinical phenotype including autistic traits, such as speech and
language deﬁcits and insistence on routine, was reported to have
a 570-kb de novo deletion of 24 genes at chromosome 11q13.1,
including NRXN2.13 However, a clear causal relationship between
NRXN2 and autism has not been established.
To begin to test the hypothesis that Nrxn2α deﬁciency
contributes to the symptoms of autism, we employed mice with
a targeted mutation (Nrxn2tm1Sud; MGI:3042719) that deletes the
ﬁrst exon of Nrxn2 and abolishes expression of Nrxn2α, but does
not affect β-neurexin II.14 The 30-day survival rate and gross brain
anatomy of Nrxn2α null mutants are unaltered compared with
wild-type littermates.14,15 In light of the putative link between
Nrxn2α and autism—diagnosis of which is based purely on
behavioral assessment—we predicted that Nrxn2α knockout
(Nrxn2α KO) mice might exhibit autism-relevant behavioral
abnormalities. Herein, we report that Nrxn2α KO mice displayed
altered anxiety-like and social behaviors consistent with a causal
role for the loss of Nrxn2α in the genesis of autism-related
behaviors.
MATERIALS AND METHODS
All the procedures were approved by the University of Leeds Animal
Ethical and Welfare Review Board and were performed under the UK Home
Ofﬁce Project and Personal Licences.
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Animals
B6;129-Nrxn3tm1Sud/Nrxn1tm1Sud/Nrxn2tm1Sud/J mice (JAX #006377) were
purchased from the Jackson Laboratory (Bar Harbor, ME, USA) as
heterozygous KO at Nrxn1, homozygous KO at Nrxn2 and wild-type at
Nrxn3. We subsequently outbred to the C57BL/6NCrl strain (Charles River,
Margate, UK) to obtain mice that were Nrxn2α KO heterozygotes, but wild-
type at Nrxn1 and Nrxn3. Nrxn2α KO heterozygotes were then intercrossed
to obtain wild-type (WT) and KO littermates. DNA extracted from ear
biopsies was used for PCR-based genotyping according to the Jackson
Laboratory Nrxn1 v5, Nrxn2 v5 and Nrxn3 v1 protocols (http://jaxmice.jax.
org/strain/006377.html#genotype). Brieﬂy, the primers 5′-GAGATGGAG
AGCCAGACACC-3′ (common forward), 5′-CAGTGCCATGGACTCAGTAGC-3′
(WT reverse) and 5′-GCATCGCATTGTCTGAGTAGG-3′ (KO reverse) were
used with HotShot Diamond (Clent Life Science, Stourbridge, UK) using the
thermocycling program of: 94 °C for 5 min, followed by 35 cycles of 94 °C
for 30 s, 64 °C for 60 s and 72 °C for 60 s, followed by 72 °C for 120 s. PCR
products were visualized using electrophoresis, with a 190-bp band
indicating the WT allele, and a 310-bp band indicating the KO allele.
Litters were separated by sex at postnatal day 21, when mice were
housed with at least one other mouse of the same sex and age, with a
maximum of ﬁve mice per cage. Food and water were provided ad libitum,
except for the buried food experiment. Lighting was provided in a 12:12
dark/light cycle, with the light cycle commencing at 06:00.
Behavioral testing
All behavioral experiments were conducted using young adults over
8 weeks of age. All the mice were extensively handled before testing. WT
and KO mice were tested in the following behavioral experiments (in
order): open ﬁeld, elevated plus maze (EPM), forced-swim test, social
interaction, emergence test, novel object exploration, prepulse inhibition
(PPI), passive avoidance. For detailed methodology, see Supplementary
Materials and Methods.
Quantitative RT-PCR
WT (n= 5) and Nrxn2α KO (n=5) mice were killed by CO2 asphyxiation and
their brains were quickly extracted and snap frozen in liquid N2. Frontal
cortex and hippocampus were dissected on ice, and tissue was stored in
RNAlater (Ambion, Paisley, UK) at 4 °C for up to 7 days. RNAlater was
removed and tissue was homogenized in 1 ml TRIzol Reagent (Invitrogen,
Paisley, UK). RNA was extracted from the homogenate using a PureLink
RNA Kit (Ambion), followed by spectrophotometric analysis of purity/
integrity by 260 nm analysis of RNA concentration and 260/280 nm ratio
analysis of RNA purity. Two microlitres of each RNA sample were converted
into cDNA using a Quantitect reverse transcription kit (Qiagen, Manchester,
UK). The cDNA was stored at − 20 °C before analysis by quantitative RT-
PCR. A total of 0.1 μg of cDNA (in triplicate) was used to quantify gene
expression with a Quantitect SYBR Green quantitative RT-PCR kit (Qiagen)
using the thermocycling program of: 95 °C for 15mins, followed by 40
cycles of 94 °C for 15s, 55 °C for 30 s and 72 °C for 30s.
All the data were normalized to a Cyc1 neuronal reference gene. To
select an optimal reference gene, the stability of four genes commonly
used in real-time RT-PCR studies (Actb (β-actin), Cyc1, Pgk1 and Rpl13a) was
tested. Three different samples (with two replicates per sample) per
genotype and brain area were run for each gene. Normﬁnder software16
was used with the obtained cycle threshold (Ct) values to calculate the
expression stability of the four genes. Cyc1 was consistently the most
stable gene in both frontal cortex and hippocampus. Using a combination
of genes did not substantially improve the stability (data not shown).
Thirteen transcripts in total were studied: parvalbumin (Pvalb), GAD65
(Gad2), GAD67 (Gad1), AMPA receptor subunit 1 (Gria1), NMDA receptor
subunit 1 (Grin1), NMDA receptor subunit 2a (Grin2a), NMDA receptor
subunit 2b (Grin2b), postsynaptic density protein 93 (Dlg2), postsynaptic
density protein 95 (Dlg4), syntaxin-binding protein 1 (Stxbp1), Homer
protein 1 (Homer1), vesicular glutamate transporter (Slc17a7), and vesicular
inhibitory amino-acid transporter (Slc32a1). Primers for Stxbp1, Grin2b,
Homer1, Pgk1, Rpl13a and Cyc1 were designed using the Roche Universal
Probe Library ProbeFinder version 2.50 (Table 1) and were synthesized by
Sigma (Haverhill, UK). The remaining primers were QuantiTect Primer
Assays purchased from Qiagen.
Analysis was carried out using the 2-ΔΔCt method17 and data are
displayed as relative quantiﬁcation values, relative to WT levels.
Western blotting
WT (n= 4) and Nrxn2 KO mice (n=4), different to those used for the RT-
PCR, were killed by CO2 asphyxiation and their brains were quickly
extracted, divided into hemispheres, snap frozen in liquid N2 and
subsequently stored at − 80 °C. The cortex and hippocampus were
dissected under a microscope and homogenized at a concentration of
333 mgml− 1 in RIPA Lysis Buffer with 0.5% sodium orthovanadate, 0.5%
PMSF, 0.5% protease inhibitor cocktail (Santa Cruz, Heidelberg, Germany)
and 1× Phos-STOP (Roche, Welwyn Garden City, UK) on ice. The
homogenate was centrifuged at 4 °C, the supernatant was aliquoted and
protein concentration was measured by Bradford assay. Samples were
stored at − 80 °C. Aliquots of 30 μg total protein were prepared for loading
by the addition of Laemmli sample buffer (Bio-Rad, Hemel Hempstead, UK)
with 5% β-mercaptoethanol and incubated at 95 °C for 5 min.
Samples were subjected to gradient SDS–polyacrylamide gel electro-
phoresis (100 V, 1.5 h) on polyacrylamide gels (4–15%) (Mini-PROTEAN TGX,
Bio-Rad), transferred to BioTrace PVDF transfer membranes (Pall, Ports-
mouth, UK) (100 V 1.5 h on ice), and blocked for either 1–2 h at room
temperature or overnight at 4 °C in 5% skimmed milk in 1 × phosphate-
buffered saline with 0.05% Tween-20. Membranes were incubated with
primary antibodies in 5% milk for 1 h at room temperature or 4 °C
overnight at the following concentrations: Munc18-1 (sc-14557; Santa
Cruz) 1:1000; parvalbumin (SAB4200545; Sigma) 1:1000; PSD-95 (sc-32290;
Santa Cruz) 1:1000; GluN2A (sc-31542; Santa Cruz) 1:100. Anti-goat (sc-
2020; Santa Cruz) and anti-mouse (sc-2371; Santa Cruz) HRP-linked
secondary antibodies were incubated in 5% milk for 1 h at room
temperature. Bound peroxidase-conjugates were visualized using ECL
western blotting substrate (Promega, Southampton, UK). To conﬁrm equal
loading, membranes were immersed in stripping buffer (69mM SDS, 63mM
Tris, 0.7% β-mercaptoethanol, pH 6.8) at 50 °C for 30min before incubating
with anti-β-actin (A1978; Sigma, Poole, UK) 1:5000. All western blots were
repeated a minimum of three times. Densitometry was performed using
ImageJ (v1.46; http://imagej.nih.gov/ij), with expression normalized to the
β-actin loading control.
Data analysis
All the data are expressed as mean± s.e.m. To assess the differences
between the variables and their impact upon performance, two-sample t-
tests or analyses of variance were conducted. Performance across time
bins was analyzed by repeated measures analysis of variance. If there were
signiﬁcant interactions between variables, tests of simple main effects
were performed (Bonferroni corrected), followed by post hoc analysis
where necessary. All analyses were performed using SPSS version 20. In all
cases, α was set at ⩽ 0.05. Graphs were drawn using GraphPad Prism
version 6. Statistical signiﬁcance within the ﬁgures is represented as:
***Po0.0001, **Po0.01 and *Po0.05.
RESULTS
Nrxn2α KO mice display deﬁcits in social behavior
In view of the putative link between Nrxn2α and autism, we
assessed whether Nrxn2α KO mice with a predominantly C57BL/6
genetic background exhibit autism-related behavioral abnormal-
ities. As impaired sociability is one of the core diagnostic criteria
Table 1. Primer sequences for genes that were designed in-house
Gene Orientation Sequence (5′–3′)
Cyc1 Forward ctctcctccttggaccacac
Reverse cggtacgccacataatcca
Pgk1 Forward gaagcgggtcgtgatgag
Reverse attgtccaagcagaatttgatg
Rpl13a Forward ccctccaccctatgacaaga
Reverse gccccaggtaagcaaactt
Grin2b Forward tcatggtatcacgcagcaat
Reverse atcacccacacgtcagcac
Stxbp1 Forward agaagaagggcgagtggaag
Reverse atcttgcagcaggaggacag
Homer1 Forward ggccctctctcatgctagttc
Reverse ttgttgcctttgagggtagc
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for autism,18 we examined the social interaction of Nrxn2α KO
mice in a three-chambered assay for sociability, in which mice
were given a choice between spending time in the side with an
unfamiliar mouse enclosed in a wire cage (Stranger 1) or in the
side with an empty wire cage.19 Unlike their WT littermates,
Nrxn2α KO mice failed to show a signiﬁcant preference for the
unfamiliar conspeciﬁc. However, both genotypes spent an
equivalent amount of time in proximity to the empty cage
(Figure 1a). Following the sociability assay, subjects were given a
test for social novelty preference, with a choice between the
original unfamiliar mouse (Stranger 1) and a new unfamiliar
mouse (Stranger 2). WT mice showed a clear preference for
exploration of Stranger 2, whereas no such preference was shown
by Nrxn2α KO mice, although both genotypes spent a similar time
in proximity to Stranger 1 (Figure 1b). There was no genotypic
difference in general ambulation in the three-chambered arena, as
Nrxn2α KO and WT mice traveled similar distances during each
phase of testing (Supplementary Figure S1). To determine whether
the reduced social exploration time in Nrxn2α KO mice was
related to potential anxiety caused by the presence of a novel
conspeciﬁc, we tested the preference for exploring soiled versus
clean bedding in the same three-chambered arena using a
previously untested cohort of mice. WT mice spent a greater
proportion of time in proximity to the cage that contained the
soiled bedding, compared with that containing the clean bedding,
whereas Nrxn2α KO mice showed no bias towards either cage
(Figure 1c). To test whether the lack of sociability could be related
to a potential deﬁcit in olfaction in the Nrxn2α KO mice, we
examined their ability to locate buried food (Supplementary
Figure S1d). There was no signiﬁcant difference between the
genotypes in latency to ﬁnd the food. Three KO mice required the
full length of the experiment to ﬁnd the food, but two of these
had previously shown a preference for exploring soiled bedding
rather than clean bedding, suggesting that an olfactory deﬁcit is
unlikely.
Nrxn2α KO mice display increased anxiety in tests of exploratory
activity
In addition to the core symptoms of the disorder, autism is
characterized by a high prevalence of all diagnostic subtypes of
anxiety.20 Indeed, anxiety-related dysfunction can often be as
signiﬁcant as, or even greater than, the difﬁculties arising from the
core symptoms.21 Anxiety in Nrxn2α KO mice was assessed in four
tests of exploratory activity: the open ﬁeld, EPM, emergence and
novel object tests.
The open ﬁeld is a measure of anxiety dependent upon the
natural aversion of mice for a novel, brightly lit open arena. In this
situation, mice spontaneously prefer the periphery to activity in
the central parts of the open ﬁeld. This wall-hugging tendency,
known as thigmotaxis, is bidirectionally sensitive to anxiogenic
(increased) and anxiolytic (decreased) drugs, and is used as a
measure of anxiety in mice.22 Over 30min of free exploration in
the open ﬁeld, the total distance traveled was not signiﬁcantly
different between Nrxn2α KO and WT mice (Figure 2a). However,
Nrxn2α KO mice spent signiﬁcantly more time in the peripheral
zone near the walls (Figure 2b), signiﬁcantly less time in an
intermediate zone (Figure 2c) and showed a trend approaching
signiﬁcance (P= 0.085) for less time in the center of the arena
(Figure 2d), but there were no genotypic differences in the total
number of zone entries (Supplementary Figures S2a and c).
Nrxn2α KO mice also spent more time rearing than WT mice, but
there was no genotypic difference in the amount of time spent
self-grooming (Supplementary Figures S2d and e).
The EPM test exploits the conﬂict between the tendency of
mice to investigate a novel environment, and to avoid brightly lit
open areas. In this test, Nrxn2α KO mice spent signiﬁcantly less
time in the open arms (Figure 3a) and more time in the closed
Figure 1. Nrxn2α KO mice exhibit deﬁcits in sociability and social
memory. During the ﬁrst phase (a), whereby the test mouse had to
discriminate between a novel mouse and an empty but identical
cage, Nrxn2α KO mice (n= 16) display no signiﬁcant preference for
exploring the novel mouse compared with the empty cage, whereas
WT (n= 31) showed a very clear discrimination (repeated measure
analysis of variance (RM ANOVA), signiﬁcant genotype ×discrimina-
tion interaction; F(1,45)= 14.89, Po0.0001). Tests of simple main
effects found a signiﬁcant effect of genotype when exploring the
novel mouse (F(1,45)= 18.51, Po0.0001) but not the empty cage
(F(1,45)o1, P40.05). In stage 2 (b), the preference of the test mouse
to discriminate between the previously explored mouse (Stranger 1)
and a second novel mouse (Stranger 2) was measured. Nrxn2α KO
mice spent a similar time as WT exploring Stranger 1, but showed
signiﬁcantly less exploration of Stranger 2 (RM ANOVA, signiﬁcant
genotype ×discrimination interaction; F(1,45)= 8.08, P= 0.007). Tests
of simple main effects conﬁrmed a signiﬁcant effect of genotype on
time exploring the novel mouse (F(1,45)= 8.92, P= 0.005) but not on
time exploring the previously explored mouse (F(1,45)o1, P40.05).
Nrxn2α KO mice were also unable to discriminate between
exploring soiled vs clean bedding (c). Nrxn2α KO mice (n= 13)
showed no preference for either cage, whereas WT (n= 11) spent a
proportionately longer time exploring the cage containing the
soiled bedding (RM ANOVA, signiﬁcant genotype ×discrimination
interaction; F(1,22)= 8.37, P= 0.008). Tests of simple main effects
found a signiﬁcant effect of genotype on time exploring the soiled
bedding (F(1,22)= 5.01, P= 0.036) but not the clean bedding
(F(1,22)= 3.81, P40.05). KO, knockout; Nrxn2α, α-neurexin II; NS, not
signiﬁcant; WT, wild type. *Po0.05; **Po0.01; ***Po0.0001.
Autism-related behaviors in Nrxn2 KO mice
J Dachtler et al
3
Translational Psychiatry (2014), 1 – 8
arms (Figure 3b) than WT littermates. Nrxn2α KO mice also made
signiﬁcantly fewer exploratory head dips from the center and
open arms (Figure 3c) and spent signiﬁcantly less time on the
central square (Supplementary Figure S3a). Although Nrxn2α KO
mice made signiﬁcantly fewer total entries, and traveled
signiﬁcantly less overall than WT mice (Supplementary Figures
S3b and e), it is unlikely that hypoactivity alone can explain their
EPM behavior, as their ambulation in the other tests of exploratory
activity was unaltered.
In the emergence test, mice were placed inside a small
enclosure, and evaluated for the time taken to emerge from it
into a larger, brightly lit open arena. Emergence latencies reﬂect
anxiety levels, being shorter in rodents injected with diazepam.23
Nrxn2α KO mice took a substantially (3.7 times) longer time than
WT mice to emerge from the enclosure (Figure 3d). Over the
15min trial, Nrxn2α KO mice also spent signiﬁcantly more time in
the enclosure (Figure 3e), and made signiﬁcantly fewer entries into
the open arena (Supplementary Figure S3f) than WT mice.
State anxiety is a transient emotional response related to
exposure to a threatening stimulus, whereas trait anxiety is an
enduring feature determining propensity for anxiety.24 The EPM
and open ﬁeld tests have been described as measures of state
anxiety, whereas the novel object test in a familiar environment is
proposed to assess trait anxiety.24,25 In the novel object test,
Nrxn2α KO mice spent signiﬁcantly less time than WT littermates
exploring a novel object (Figure 3f). However, locomotor activity
was similar between genotypes during both the habituation and
test phases (Supplementary Figures S3g and h).
To assess depression-related behaviors in Nrxn2α KO mice, we
used the Porsolt forced-swim test and the tail suspension test,
both of which involve measurement of escape attempts and
behavioral despair. In each of these tests, Nrxn2α KO and WT mice
were statistically indistinguishable (Supplementary Figures S4a
and b).
Nrxn2α KO mice exhibit normal PPI and passive avoidance
learning
PPI is a robust operational measure of sensorimotor gating, a
process important for ﬁltering extraneous sensory information
from the external environment. In the few studies conducted to
date, autism patients have not shown consistent deﬁcits in
PPI,26,27 with only one study reporting decreased PPI in autistic
subjects under speciﬁc testing conditions.28 We found that Nrxn2α
KO and WT mice showed similar startle responses to varying
intensities of sound, and similar magnitudes of PPI
(Supplementary Figures S4c and d), thereby suggesting normal
sensorimotor gating in Nrxn2α KO mice.
Up to 40% of individuals with autism have IQ scores low
enough (o35) to be classiﬁed within the range of severe-to-
profound intellectual disability.29 Conversely, a man with speech
problems, autistic traits and deletion of the whole NRXN2 gene
was reported to have an IQ of 113 in a nonverbal intelligence test,
suggesting that his mental impairment was primarily restricted to
speech and language.13 Therefore, we examined long-term (24-h)
memory in Nrxn2α KO mice using step-through passive avoid-
ance, a fear-motivated test that requires the subject to refrain
from entering a speciﬁc environment (a dark chamber) in which
an aversive stimulus (a mild electric shock) has previously been
experienced. We found that Nrxn2α KO and WT mice had similar
retention latencies 24 h after the electric shock was given
(Supplementary Figure S4e), indicating normal cognitive perfor-
mance in this hippocampus-dependent test.30
Nrxn2α KO mice show a decrease in hippocampal Munc18-1
Mice with deletion of other genes implicated in autism have
shown differences in the level of synaptic proteins,31 so we used
real-time RT-PCR analysis to measure the mRNA levels of 13 genes
encoding synaptic proteins to ascertain whether their expression
Figure 2. Activity of Nrxn2α KO mice in the open ﬁeld. (a) Nrxn2α KO mice (n= 16) display a marginal but non-signiﬁcant increase in
locomotion compared with WT mice (n= 33) over 30min of free exploration (two-way repeated measures analysis of variance, main effect of
time block (F(5,235)= 18.12, Po0.0001), no effect of genotype (F(1,47)= 2.44, P40.05) or interactions (F(5,235)o1, P40.05)). During the trial, the
arena ﬂoor was divided into three zones (outer, intermediate, center) and the mice were tracked automatically. Nrxn2α KO mice spent
signiﬁcantly more time within the outer zone (b; t(47)= 2.54, P= 0.015; thigmotaxis) and signiﬁcantly less time in the intermediate zone (c;
t(47)= 2.59, P= 0.013). There was also a trend for Nrxn2α KO mice to spend less time in the center zone (d; t(47)= 1.76, P= 0.085). KO, knockout;
Nrxn2α, α-neurexin II; WT, wild type. *Po0.05.
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was altered by Nrxn2α deﬁciency. These genes were chosen on
the basis of either known direct interactions with neurexin at the
presynapse (for example, Stxbp1) or indirectly via neuroligins at
the postsynapse (for example, Dlg4, Pvalb). We examined mRNA
levels in two brain regions: the frontal cortex and hippocampus,
both of which have links to autism.32,33 Dlg4, encoding PSD-95,
was the only transcript tested that had altered mRNA levels in
both the frontal cortex and hippocampus, with expression
signiﬁcantly decreased in Nrxn2α KO mice. In the hippocampus,
the mRNA levels of genes that encode proteins involved in both
inhibitory (Pvalb; parvalbumin; Figure 4a) and excitatory (Grin2a;
NMDA receptor subunit 2a; Figure 4b) transmission were
signiﬁcantly decreased in Nrxn2α KO mice. The mRNA level of
Stxbp1, encoding Munc18-1, was also signiﬁcantly reduced in the
Nrxn2α KO hippocampus (Figure 4c). Munc18-1 has been shown
to interact presynaptically with neurexins to facilitate presynaptic
vesicular release.34
To determine whether these transcriptional changes led to
detectable changes in protein abundance, we tested homogenates
of frontal cortex and hippocampus by western blotting. Within the
hippocampus, there was a signiﬁcant reduction in the abundance of
Munc18-1 (Figures 4e and f), but there was no signiﬁcant difference
in the frontal cortex. None of the other genes with signiﬁcantly
different mRNA levels in Nrxn2α KO mice showed detectable
differences in protein abundance (Supplementary Figure S5).
DISCUSSION
Although there has been increasing focus upon the etiology of
autism, its genetic basis remains poorly deﬁned. Despite this, an
Figure 3. Nrxn2α KO mice show an anxiety-like phenotype. In the elevated plus maze, KO mice (n= 16) spent signiﬁcantly less time in the
open arms (a; t(47)= 2.62, P= 0.012) and signiﬁcantly more time in the closed arms (b; t(47)= 6.84, Po0.0001) compared with WT (n= 33). KO
mice also make signiﬁcantly fewer head dips (c; t(47)= 4.68, Po0.0001). In the emergence test, the latency to emerge from an enclosed shelter
into an open arena was signiﬁcantly longer in Nrxn2α KO mice (n= 16) compared with WT (n= 33) (d; t(47)= 4.16, Po0.0001) and, overall, they
spent signiﬁcantly less time out of the enclosed shelter over the 15 min trial (e; two-way repeated measures analysis of variance, main effect of
time block (F(2,94)= 14.34, Po0.0001) and genotype (F(1,47)= 12.30, P= 0.001), no signiﬁcant interactions (F(2,94)= 2.01, P40.05)). In a familiar
environment, Nrxn2α KO mice also spent signiﬁcantly less time engaging with novel objects (f; t(47)= 2.86, P= 0.006). KO, knockout; Nrxn2α,
α-neurexin II; WT, wild type. *Po0.05; **Po0.01; ***Po0.0001.
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increasing body of evidence has implicated the neurexin gene
family in autism. Although deletions of NRXN1 are associated with
autism,35 recent studies have also discovered deletions affecting
NRXN2 in autism patients,12,13 although a causative link between
NRXN2 and autism has not been established. In the present study,
we found that deletion of the Nrxn2α gene in mice can replicate
some of the core symptoms of autism. We found that Nrxn2α KO
mice show reduced sociability, while also exhibiting an anxiety
phenotype in the open ﬁeld, EPM and emergence tests. Following
quantiﬁcation of mRNA extracts and protein expression, we found
that deletion of Nrxn2α is associated with decreased expression of
the presynaptic protein Munc18-1, which may potentially
contribute to the altered behavioral state of Nrxn2α KO mice.
The diagnosis of autism in humans is made upon assessment of
aberrant behavioral phenotypes, typically social, communication,
repetitive and stereotyped behaviors. We found that Nrxn2α KO
mice fail to show sociability with novel conspeciﬁcs or a
preference for exploring social odors. This behavioral phenotype
is thus consistent with one of the core symptoms of autism. A
similar phenotype is shown by Shank3 KO mice, which also
genetically model a mutation found in autism, with deﬁcits in
sociability and social recognition.35 However, given the lack of
initial sociability in Nrxn2α KO mice, it is difﬁcult to determine to
Figure 4. Altered mRNA transcript and protein expression levels in the frontal cortex and hippocampus of Nrxn2α KO brain. The 13 genes
examined were divided into groups of inhibitory-related (a), excitatory-related (b) and synaptic scaffold-related (c). Within the frontal cortex,
Nrxn2α KO mice showed signiﬁcant reductions in the mRNA level of Dlg4, whereas in the hippocampus, Pvalb, Grin2a, Stxbp1 and Dlg4 were
also reduced. Gad1 and Slc17a7 (VGlut1) both had reductions approaching signiﬁcance (note in a and b, #P= 0.059 and #P= 0.086,
respectively). (d) Summary of the signiﬁcantly altered genes (unpaired t-test). (e and f) Within the hippocampus, western blotting conﬁrmed a
decrease in the protein expression of Munc18-1 (Stxbp1) (t(22)= 2.31, P= 0.031), although there was no signiﬁcant difference in the cortex
(P40.05). KO, knockout; Nrxn2α, α-neurexin II; RQ, relative quantiﬁcation; WT, wild type. *Po0.05.
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what extent social memory was actually affected. In contrast, mice
null for another gene in the neurexin family, α-neurexin I (Nrxn1α),
have shown heightened sociability, with signiﬁcantly more time
spent exploring the stranger mouse in the three-chamber social
approach test and more aggression towards juvenile
conspeciﬁcs,36 although another study observed unaltered
sociability.37 Nrxn2α KO mice may thus model social deﬁcits
associated with autism better than Nrxn1α KO mice. Although it is
conceivable that the generalized anxiety phenotype of Nrxn2α KO
mice could have inﬂuenced their performance in the three-
chamber social approach test, the similar total locomotion of
Nrxn2α KO and WT mice across all phases of the test indicates that
there was not an effect of hypoactivity (Supplementary Figure S1).
Nrxn2α KO mice did not model other core symptoms of autism
in the behavioral tests that we carried out. Within the open ﬁeld,
they did not exhibit stereotyped repetitive behaviors, as have
been observed in Shank3 KO mice,38,39 16p11.2 deletion mice40
and Nrxn1α KO mice.37 Nrxn2α KO mice may simply not exhibit
this phenotype, or the anxiogenic effect of the open ﬁeld may
have reduced the chance of observing repetitive behaviors.
Altered communication is also a hallmark of autism. Changes in
ultrasonic vocalization have been found in Shank3 KO mice,39 but
we did not test for this phenotype.
Autism is frequently comorbid with reduced intellectual
ability.41 To assess long-term memory, we used the fear-
motivated passive avoidance test, but found no impairment in
Nrxn2α KO mice. It is possible that Nrxn2α deletions do not
directly impair intellectual capacity, as the male patient with a
whole gene deletion of NRXN2 had an IQ of 113, although he did
have deﬁciencies in speech and language.13 Similarly, Nrxn1α KO
mice did not show cognitive impairments in the Morris water
maze.37 However, as Nrxn1α deletions have been found in
mentally retarded subjects without autism,42 further work is
warranted to understand the role of the neurexins in cognitive
processes.
We observed an anxiety phenotype in Nrxn2α KO mice across
several different paradigms. In autism patients, it has been noted
that anxiety can exacerbate other symptoms, and treatment of
anxiety by cognitive behavioral therapy can improve the social
skills of patients.20,21 Nrxn2α KO mice provide a tool to further
explore the links between autism and anxiety. Nrxn1α KO mice
exhibit milder anxiety-like behavior, making fewer transitions in a
light/dark box36 while showing no abnormalities in the EPM.37
Other mouse models of autism have also shown anxiety
phenotypes, including Shank3 KO mice that spent less time in
the open arms of the EPM.38
At the gene transcript level, we used quantitative RT-PCR to
discover that various genes, normally associated with excitatory
and inhibitory transmission, were downregulated in the Nrxn2α
KO brain. However, only Munc18-1 showed detectable alterations
at the protein level in western blotting assays. It is unclear why the
decreased transcript levels of the other genes were not reﬂected
in the abundance of their encoded proteins. Western blotting
assays are, at best, only semi-quantitative, limited in their ability to
detect small differences in protein levels. In accordance with the
primary antibody suppliers’ recommendations, total protein
samples of 30 μg were loaded into each lane. Although loading
less total protein or just the synaptosomal fraction might,
conceivably, increase the sensitivity of western blotting, 40 μg of
whole-brain homogenates were previously used to reveal the
differences in synaptic proteins in Nlgn1 KO mice deﬁcient in
neuroligin-1,31 a transmembrane protein that complexes with β-
neurexin to form a functional excitatory synapse.43 Moreover,
changes in gene expression level are frequently not reﬂected at
the protein level;44 for example, a study using both RNA
sequencing and quantitative mass spectrometry to calculate
absolute mRNA and protein copy numbers in the same mouse
ﬁbroblasts found that mRNA levels explained only ~ 40% of
protein level variation.45
A 21% decrease in the abundance of Munc18-1 in the brain has
previously been found in Nlgn1 KO mice that display impaired
spatial memory and increased repetitive behavior.31 Interestingly,
a genome-wide copy number variation analysis has implicated
NLGN1 as a candidate gene in autism susceptibility.46 A signiﬁcant
decrease in expression of Munc18-1 could conceptually be
important for both excitatory and inhibitory transmission.
Munc18-1 is found at the presynapse and holds a critical role in
facilitating presynaptic vesicular release through its interactions
with syntaxin-1.34 Furthermore, Munc18-1 can link to neurexins via
its cytoplasmic tail through a complex that involves Mint1.4 In
Munc18-1 KO mice, there is a complete loss of neurotransmitter
secretion from synaptic vesicles47 by a reduction in docked
vesicles at the active zone,48 whereas in heterozygotes the readily
releasable pool is more easily depressed at glutamatergic and
GABAergic synapses.49 Munc18-1 heterozygotes also show
enhanced anxiety and impaired emotional learning.50 As altered
Munc18-1 expression is likely just one of many synaptic
modiﬁcations caused by the loss of Nrxn2α during development,
further work is warranted to understand the molecular pathways
that underpin the behaviors observed in Nrxn2α KO mice.
The robust deﬁcit in social interaction and the heightened
anxiety of Nrxn2α KO mice are consistent with a causal role for the
loss of Nrxn2α in the genesis of autism-related behaviors, as
suggested by the previous ﬁnding of deletions affecting exons of
the NRXN2 gene in two unrelated individuals with autism.12,13
Nrxn2α KO mice may thus provide a useful experimental system
for the exploration of disease mechanisms and novel treatments
in autism.
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